Morningstar® Stock Report™

石藥集團有限公司 01093

Gewinnmarge (% des Umsatzes)
20192020202120222023
Ertrag100,00%100,00%100,00%100,00%100,00%
Betriebskosten28,02%25,09%24,16%28,06%29,49%
Bruttogewinn71,98%74,91%75,84%71,94%70,51%
Vertriebsgemeinkosten42,80%41,39%41,10%37,21%32,85%
Forschung und Entwicklung9,05%11,59%12,32%12,89%15,36%
Umsatzrendite20,81%24,28%24,38%21,85%22,31%
Net Int, Inc and Other41,74%49,91%48,95%46,36%45,80%
EBIT Marge20,93%25,62%24,57%24,51%23,50%
Ertragskraft
20192020202120222023
Steuersatz4,04%4,66%4,16%4,36%4,19%
Nettomarge16,80%20,69%20,11%19,69%18,68%
Gesamtkapitalrendite15,0118,3017,3015,9213,34
Financial Leverage1,431,351,341,381,39
Eigenkapitalsrendite22,1825,3023,2021,6818,53